Surgical Robots Market Size, Share & Trends Analysis Report By Application (Orthopedics, Neurology, Urology, Gynecology), By End-use (Inpatient, Outpatient), By Region (North America, Europe), And Segment Forecasts, 2025 - 2030

Surgical Robots Market Size & Trends

The global surgical robots market size was valued at USD 4.31 billion in 2024 and is expected to grow at a CAGR of 9.42% from 2025 to 2030. The shortage of physicians and surgeons all over the globe and the increasing adoption of automated instruments used for surgery are the major factors driving market growth. In addition, rising technological advancements, increased investments from regional and international players, and a rise in chronic diseases, along with knee and hip replacement surgeries, are driving growth. According to the American College of Rheumatology, approximately 790,000 total knee replacements and 544,000 hip replacements are performed annually in the U.S., and this number continues to grow as the population ages.

Moreover, as per the American Academy of Orthopedic Surgeons (AAOS) study published in November 2024, over 3.7 million total hip and knee replacement surgeries took place at 1,447 facilities across all 50 states and the District of Columbia during the period from 2012 to 2023.

In addition, benefits associated with these surgical procedures include less pain & blood loss, shorter recovery period, lower risk of infections at the surgical site, and smaller or less noticeable scars, thereby aiding market growth. For instance, according to a study published by the Hip and Knee Society comparing the 90-day care costs between patients who received a Mako total knee replacement and patients who underwent conventional knee surgery, the cost of care for patients receiving treatment using Mako was USD 2,400 lesser than that for those patients who received conventional knee replacement. Moreover, the study revealed that a reduction of 33% in 90-day readmissions was observed in patients receiving treatment using Mako.

The increasing prevalence of bone degenerative diseases, such as arthritis and osteoporosis, is driving a surge in hip and knee replacement surgeries, significantly impacting market growth. Osteoporosis impacts around 10 million individuals in the U.S., and approximately 75 million people across the U.S., Europe, and Japan collectively. In addition, projections suggest that by 2040, 1 in 4 U.S. adults (78.4 million) will have doctor-diagnosed arthritis, and 1 in 9 adults (34.6 million) will experience arthritis-attributable activity limitations. As the demand for joint replacement procedures rises, advancements in robotic-assisted surgery are transforming the orthopedic landscape by improving precision, reducing recovery times, and enhancing patient outcomes.

Moreover, the market is being driven by the growing prevalence of chronic diseases such as heart disease, cancers and others. For instance, a report from the World Health Organization in February 2024 highlighted that there were over 20 million new cancer cases worldwide, with 53.5 million individuals surviving at least five years of post-diagnosis.

The growing investments from both regional and international stakeholders in the development of advanced surgical robots are contributing positively to the market’s expansion. Enhancements in visualization and navigation, particularly through Surgical Navigation Systems, are essential for the technological advancement of Robotic Surgical Procedures. High-definition 3D cameras and augmented reality overlays provide surgeons with an immersive perspective of the surgical area, improving their spatial awareness and decision-making skills. For instance, in February 2024, CMR Surgical launched its latest innovation, the vLimeLite. This integrated fluorescence imaging system is designed to enhance surgical procedures by providing surgeons with improved visualization capabilities using Indocyanine Green (ICG). ICG is a fluorescent dye that is commonly used in medical imaging to visualize blood flow and tissue perfusion.

In addition, as per the American College of Surgeons report published in May 2023, over 12 million surgeries have been performed using da Vinci systems globally, underscoring the widespread acceptance and reliance on robotic-assisted surgical technologies. The 22% increase in surgical procedures utilizing these systems from 2022 to 2023 signifies a growing trend toward adopting advanced surgical technologies. This surge in demand reflects the effectiveness of robotic systems and a shift in surgical practices toward minimally invasive techniques that improve patient outcomes and reduce recovery times.

Market Concentration & Characteristics

The surgical robots market is characterized by a high degree of innovation. The latest technological advancements in medical robotic systems have demonstrated enhanced dexterity and precision. These advancements include improved articulation, tremor filtration, and visualization, enabling surgeons to conduct intricate procedures with unparalleled accuracy and minimal tissue damage. For instance, in February 2023, CK Birla Hospital in India made a significant advancement in orthopedic surgery by introducing fully active robotic technology for minimally invasive knee replacement procedures. This surgical robot system accurately assesses deformities, 3D pre-planning, and precise surgical results for better patient outcomes.

The industry is characterized by medium merger and acquisition activity, owing to several factors, including the desire to expand the business to cater to the growing demand for robotics surgery to maintain a competitive edge. For instance, in August 2024, Asensus Surgical announced the completion of its acquisition of Karl Storz, a manufacturer of endoscopic equipment. This strategic move is aimed at enhancing Asensus Surgical’s capabilities in the field of minimally invasive surgery by integrating Karl Storz’s extensive product portfolio and expertise in visualization technologies.

Asensus Surgical President and CEO said,“By joining forces with a leading company in endoscopy that became a system provider for integrated MedTech, we are well-positioned to accelerate the development and delivery of our innovative robotic and digital surgical solutions. This union will benefit patients and surgeons worldwide by advancing precise, safer, and more predictable surgical outcomes."

Surgical robots are often referred to as robotic-assisted surgery devices. These devices are presently approved in the U.S. by the FDA and by EU & CEA in Europe. Certification by these authorities is required for the commercialization and marketing of these devices in 27 EU nations. Surgical robots are classified as Class-II devices as per the U.S. FDA risk-based classification and Class IIa (low risk) or Class IIb (high risk) in Europe. For any medical device, the process of securing the U.S. FDA 510(k) premarket approval & Europe CE Mark is a major barrier to commercializing the product and requires a considerable investment of time and resources.

Several market players are expanding their business by launching new products and getting approvals from regulatory authorities to strengthen their market position and expand their product portfolio. For instance, in November 2024, Johnson & Johnson MedTech announced that the U.S. Food & Drug Administration (FDA) granted approval for the OTTAVA robotic surgical system under an investigational device exemption (IDE). This approval allows the company to begin clinical trials with this advanced surgical technology.

Application Insights

Based on application, the orthopedics segment held a significant revenue share in 2024. The increasing prevalence of musculoskeletal disorders, such as lower back pain, rheumatoid arthritis, osteoarthritis, & osteoporosis, and increasing market competition. The renowned medical technology companies are making significant progress in the orthopedic robotics market. For instance, in July 2024, Stryker set a record for the installation of its Mako orthopedic robot, which is designed to assist surgeons in performing joint replacement surgeries with greater precision. This achievement marks the third consecutive quarter of record installations, indicating robust demand for their robotic systems. The CEO of Stryker, Kevin Lobo, emphasized that these high installation rates are expected to lead to strong future demand for hip and knee procedures. In 2018, more than 76,900 knee and hip replacement procedures were performed by these Mako surgical robots.

The neurology segment is anticipated to grow at the fastest CAGR over the forecast period, owing to the growing prevalence of neurological disorders and increasing demand for minimally invasive techniques for performing delicate brain surgeries. For instance, the ROSA ONE Brain robotic platform is extensively used by surgeons while performing minimal invasive brain procedures. Moreover, companies are launching surgical robots in high demand for robots in minimally invasive procedures. For instance, in September 2024, ZEISS launched the KINEVO 900 S, a cutting-edge Robotic Visualization System designed specifically for neurosurgery and other surgical disciplines. This system represents a significant advancement over its predecessor, the KINEVO 900, which was first introduced in 2017 and has since been utilized in millions of surgeries worldwide.

End-use Insights

Based on end use, the inpatient (hospital) segment dominated the market with a revenue share of around 53% in 2024 as healthcare facilities are increasingly adopting robotic technology to enhance surgical procedures. These sophisticated robots offer precision, minimally invasive techniques, and improved patient outcomes. In January 2025, Prashanth Hospitals inaugurated the Institute of Robotic Surgery, introducing a state-of-the-art surgical robotic system designed for minimally invasive surgeries. This launch indicates a significant advancement in surgical technology within the healthcare sector. With its array of features designed to enhance precision and patient safety, along with its applicability across various specialties, this innovation is poised to transform how surgeries are performed.

The outpatient (ASCs, surgical centers) segment is anticipated to grow at the fastest CAGR over the forecast period. These facilities are harnessing the power of surgical robots to offer patients minimally invasive and highly precise surgeries, translating into quicker recovery times and reduced healthcare costs. The growing trend toward outpatient robotic surgeries underscores the industry's commitment to providing accessible, efficient, and patient-centric surgical solutions outside traditional hospital settings.

Regional Insights

North America surgical robots market dominated the global industry with a revenue share of 49.82% in 2024. The improvements in surgeries and healthcare facilities for various disorders are increasing the need for surgical robots for surgeries and treatment in North America. Rigorous R&D pertaining to ergonomically designed workstations to improve learning curves and growing clinical adoption of new minimally invasive surgery techniques is expected to boost market growth. In April 2023, the first commercial surgical procedure in North America utilizing the Medtronic Hugo robotic-assisted surgery (RAS) system was successfully completed at Toronto General Hospital (TGH), which is part of the University Health Network (UHN). This significant milestone involved a partial nephrectomy performed by a team of surgeons led by Dr. Antonio Finelli, who is the head of the urology division at UHN.

U.S. Surgical Robots Market Trends

The surgical robots market in U.S. dominated the North American region in 2024. The growing adoption of minimally invasive procedures in the country is due to the need for shorter recovery periods. According to the World Bank, GDP per capita in the U.S. was USD 63,543.6 in 2020. It was reported to be USD 65,279.5 in 2019, USD 63,064.4 in 2018, and USD 60,109.7 in 2017. Furthermore, the presence of a well-developed healthcare infrastructure in the country, ongoing advancements in robots, and the presence of key market players are anticipated to drive the market over the forecast period. For instance, the country is home to major companies, such as Intuitive Surgical, Medtronic, and TransEnterix Surgical, Inc. Furthermore, ongoing investments in the country are encouraging startups to launch innovative surgical robots, which are anticipated to drive the market over the forecast period.

Europe Surgical Robots Market Trends

The surgical robots market in Europe is expected to grow significantly over the forecast period. Factors such as the presence of a well-developed healthcare infrastructure and favorable reimbursement policies that reduce out-of-pocket expenditure of patients are primarily boosting the market. In addition, ongoing research on robots in the region is expected to drive market growth over the forecast period. For instance, EU-funded research studies are promoting the development of innovative microrobot technologies, which are less invasive and affordable, to minimize complications of complex surgeries.

Germany surgical robots market is expected to grow significantly during the forecast period. The presence of high-quality healthcare infrastructure and favorable reimbursement policies are key factors expected to drive this market. As per World Bank healthcare expenditure as total (% of GDP) estimates, Germany allocates nearly 11.4% of GDP toward healthcare expenditure in 2018. According to the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), in November 2020, over 90% of the total population was reportedly covered by Statutory Health Insurance Fund (SHIF) and less than 10% were covered by private insurance. Various factors driving the market in Germany include increasing government initiatives for launching local surgical robots and continuous improvements in robots & medical technology in the country.

Asia Pacific Surgical Robots Market Trends

The surgical robots market in Asia Pacific is expected to register the fastest growth rate over the forecast period. Increasing government initiatives undertaken to encourage healthcare providers and other healthcare organizations to adopt technologically advanced medical devices & systems is a key factor indicated to drive surgical robots market. In terms of adoption of technology in the APAC region, Japan, Singapore, Australia, and South Korea have been adopting technology on a large scale in the healthcare sector whereas Thailand, China, India, and Malaysia are the emerging markets.

China surgical robots market is anticipated to register considerable growth during the forecast period. include increasing partnerships and the launch of products in the Chinese market are expected to drive market growth. The growing modernization of domestic production facilities is leading to an increase in the manufacturing of medical robots in China. China’s use of robotic systems combined with satellite communication represents a groundbreaking step forward in remote surgery capabilities, potentially transforming how medical care is delivered across great distances. For instance, in January 2025, Chinese surgeons successfully conducted remote surgeries using advanced robotic systems and satellite technology. This innovative approach allows surgeons to operate on patients located thousands of kilometers away, demonstrating a significant advancement in medical technology.

Latin America Surgical Robots Market Trends

The surgical robots industry in Latin America is expected to witness considerable growth over the forecast period. The growing prevalence of chronic diseases, the easy availability of newer technologies & robots, and the increasing prevalence of osteoporosis are among the factors driving market growth in this region. For instance, according to the International Osteoporosis Foundation, in Latin America, the economic burden of hip fractures would cost USD 13 billion by 2050.

Brazil surgical robots industry is anticipated to register considerable growth during the forecast period. As per estimates of the World Bank, Brazil spends nearly 9.5% of its GDP in the healthcare sector and is one of the fastest growing industries in Latin America, owing to its leading healthcare expenditure. Growing disposable incomes, increasing access for private healthcare companies to a large population pool, increasing government medical expenditure, and rapid expansion of healthcare R&D are key factors expected to drive the markets for technologically advanced medical devices.

Middle East and Africa Surgical Robots Market Trends

The surgical robots market in the Middle East and Africa is anticipated to witness considerable growth over the forecast period. High cancer incidence and lack of skilled professionals in this region are boosting the need for robotic-assisted surgeries. In January 2025, King Faisal Specialist Hospital and Research Centre (KFSH&RC) successfully performed a groundbreaking surgical procedure. This event marks an important advancement in healthcare services provided by the institution, which is known for its commitment to excellence in patient care and medical research.

South Africa surgical robots industry is anticipated to register considerable growth during the forecast period. There is a significant shift in the medical technology (medtech) landscape in Africa, particularly focusing on the introduction of the Da Vinci Surgical Robot and its pay-per-use equipment model. The installation of a Da Vinci surgical robot at Busamed Gateway Private Hospital in Kwazulu Natal in August 2024, represents a significant advancement in the accessibility of advanced medical technology in Africa. This development is particularly noteworthy as it allows healthcare facilities to utilize state-of-the-art robotic surgery without incurring the substantial capital costs typically associated with such technologies.

Key Surgical Robots Company Insights

Key participants in the surgical robots industry are focusing on devising innovative business growth strategies, such as expanding their product portfolios, partnerships and collaborations, mergers and acquisitions, and expanding their business footprints.

Surgical Robots Market, Established and Emerging Players Analysis.

Recent Developments

• In June 2024, Indian medical device company Meril launched its MISSO surgical robot for knee replacement surgeries, claiming a 98% success rate. This indigenously developed system is designed to be cost-effective, reducing investment by 66% compared to imported systems. It makes robotic surgery more accessible, especially in smaller hospitals. The technology has received approval from CDSCO and is awaiting CE and USFDA approvals.

• In June 2024, MicroPort MedBot, received approval for its Toumai robot from regulatory authorities in the European Union (EU). This milestone signifies an important step for the company as it seeks to expand its presence in the European market and enhance surgical capabilities through advanced robotic technology.

• In June 2024, Smith+Nephew introduced a new service called CORIOGRAPH, which is designed to enhance the capabilities of their CORI Surgical System. This service focuses on personalized pre-operative planning and modeling for both patients and surgeons. The aim is to improve surgical outcomes by providing tailored insights that can help with decision-making prior to surgery.

Surgical Robots Market Report Scope

Global Surgical Robotics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global surgical robots market report based on application, end-use, and region:

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Orthopedics

    • Hip

    • Knee

    • Spine 

    • Others

  • Neurology

  • Urology

  • Gynecology

  • Others

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Inpatient

  • Outpatient

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait